Details of the Drug
General Information of Drug (ID: DM6Y2XK)
Drug Name |
3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
NSC88622; 3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine; NSC-88622; 13117-35-6; CHEMBL360575; AC1Q3WPU; NCIStruc2_000554; NCIStruc1_000767; AC1L1D58; SCHEMBL3957606; N,N-DIMETHYLHOMOTRYPTAMINE; DTXSID00275574; ZINC393884; NCI88622; NCGC00013925; BDBM50162709; CCG-38332; AKOS024323101; MCULE-7123094039; NCGC00097034-01; NCGC00013925-02; NCI60_041964; [3-(1H-indol-3-yl)propyl]dimethylamine; [3-(1H-Indol-3-yl)-propyl]-dimethyl-amine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 202.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||